Citigroup’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.04M | Buy |
359,422
+57,870
| +19% | +$811K | ﹤0.01% | 1408 |
|
|
2025
Q1 | $4.72M | Sell |
301,552
-25,713
| -8% | -$402K | ﹤0.01% | 1440 |
|
|
2024
Q4 | $4.56M | Buy |
327,265
+237,643
| +265% | +$3.31M | ﹤0.01% | 1489 |
|
|
2024
Q3 | $833K | Buy |
89,622
+35,023
| +64% | +$326K | ﹤0.01% | 2689 |
|
|
2024
Q2 | $508K | Sell |
54,599
-661,841
| -92% | -$6.16M | ﹤0.01% | 2691 |
|
|
2024
Q1 | $7.1M | Buy |
716,440
+703,727
| +5,535% | +$6.97M | ﹤0.01% | 1065 |
|
|
2023
Q4 | $41.1K | Sell |
12,713
-164,109
| -93% | -$530K | ﹤0.01% | 3873 |
|
|
2023
Q3 | $939K | Buy |
176,822
+23,234
| +15% | +$123K | ﹤0.01% | 1969 |
|
|
2023
Q2 | $1.46M | Sell |
153,588
-90,411
| -37% | -$862K | ﹤0.01% | 1952 |
|
|
2023
Q1 | $2.68M | Buy |
243,999
+110,771
| +83% | +$1.22M | ﹤0.01% | 1375 |
|
|
2022
Q4 | $1.97M | Sell |
133,228
-27,273
| -17% | -$404K | ﹤0.01% | 1532 |
|
|
2022
Q3 | $3.07M | Buy |
160,501
+114,683
| +250% | +$2.19M | ﹤0.01% | 1348 |
|
|
2022
Q2 | $976K | Buy |
45,818
+34,215
| +295% | +$729K | ﹤0.01% | 2093 |
|
|
2022
Q1 | $223K | Sell |
11,603
-108,637
| -90% | -$2.09M | ﹤0.01% | 3352 |
|
|
2021
Q4 | $2.49M | Buy |
120,240
+95,304
| +382% | +$1.98M | ﹤0.01% | 1808 |
|
|
2021
Q3 | $596K | Sell |
24,936
-36,483
| -59% | -$872K | ﹤0.01% | 2777 |
|
|
2021
Q2 | $1.68M | Buy |
61,419
+8,087
| +15% | +$221K | ﹤0.01% | 2222 |
|
|
2021
Q1 | $1.54M | Buy |
53,332
+47,904
| +883% | +$1.39M | ﹤0.01% | 2091 |
|
|
2020
Q4 | $153K | Sell |
5,428
-4,456
| -45% | -$126K | ﹤0.01% | 3394 |
|
|
2020
Q3 | $290K | Buy |
9,884
+6,873
| +228% | +$202K | ﹤0.01% | 2566 |
|
|
2020
Q2 | $91K | Sell |
3,011
-3
| -0.1% | -$91 | ﹤0.01% | 3504 |
|
|
2020
Q1 | $90K | Buy |
+3,014
| New | +$90K | ﹤0.01% | 3350 |
|